I just tried the link again and didnt work so I will paste it for you
Take note what Mike Millers response was!.....I am thinking the same thing as you.
Vivus, of Mountain View, Calif., received more bad news about its
MUSE product, an impotence treatment that must be inserted directly into
the urethra. Sales have declined dramatically since the much more
convenient Viagra was approved, according to IMS America, a
market-research firm. Now a study presented by researchers from
Presbyterian Hospital in Dallas showed that the treatment may be far less
effective than believed.
The Dallas researchers tested the drug on 115 impotent men and found
that it only helped 27% of them achieve rigidity sufficient for intercourse,
while it caused penile pain and burning in 41% of patients; only 18% of
patients in the study decided to renew their prescriptions. This study
contradicts a much larger study published last year in the New England
Journal of Medicine showing that MUSE helped 65% of men get erections
sufficient for sex.
The Dallas researchers, led by urologist Pat Fulgham, said that typical
patients using MUSE might have more severe problems than patients in the
clinic trial. Doctors noted that MUSE is difficult to use as well. Vivus
discounted the study's results. "MUSE will do very well on Viagra
failures," said Mike Miller, Vivus's marketing director. Finally, urologist
Irwin Goldstein of Boston University School of Medicine said a
preliminary test of MacroChem's Topiglan topical impotence treatment,
applied to the tip of the penis, found the drug often worked without the
burning sensations reported in some previous tests. However, this
preliminary test was done in a doctor's office and doesn't necessarily
predict how well the drug would work in the patients' bedrooms, he noted. |
